IFNAR1 and photosensitivity disease: Importantly, therapeutic blockade of IFNAR effectively suppresses this immunopathogenic cascade, supporting IFN-I pathway inhibition as a targeted strategy to prevent UVB-induced disease recurrence and exacerbation in photosensitive diseases.